Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Dr Suzy Dilly commented "I've been honoured to play a leading role in establishing the new preclinically-focussed strategy for ValiRx in the period since my appointment in 2020, and as the Company grows it is appropriate for an individual with experience of leading larger companies is sought to better serve the Company's needs. I remain committed to serving the best interests of our shareholders, our staff and collaborators, and will be available to provide support both to the search and to the integration of the incoming team members."
Tommy, Tommy, Tommy!
Have you forgotten that you told us quite recently that you had emailed SNG asking for an update!
Do make your mind up! I am going to add a third camp.. Those who believe in the drug, they have
paid for its development in the placing, they are also paying the wages, they rightly expect to
be kept updated, as promised at the AGM. They are quite rightly disappointed to be ignored
and shown no respect. They still hope the trials will start in H1 without the need for further funds!
They are also realistic and acknowledge things may not be on track and that could have consquences
for all invested here.... !
I think we are still here because we believe SNG001 can save lives..
The issue is RM & Co. managing the process to prove it....
GLA!
That is all you need to know !
Plans are underway and Lorna is a great communicator, we are kept well updated..
This is a very rare investment opportunity, don't waste it! IMHO!
If you believe this nonsense you should not be investing..
NOTHING posted on a chat board affects a stock... A few
day traders try it on... DYOR and ignore them. Occasionally
a good link to news is posted on here, or an article that you may
have missed. There are well known day traders on this site
and my advice is just filter them, they are a bore, not investors!
The MM's played this to get cheap shares... The last
RNS was great news, and things are moving fast for
our sector, you cannot do things in weeks to appease
impatient traders... Famous quote from Warren Buffett..
"The stock market is a device which transfers money from the impatient to the patient."-Warren Buffett
Well Fruits
Let's look at this another way, what deals have been done in the last 10 years???
Name one thing RM has achieved???
Denial is the enemy of the investor. One key thing to look for on AIM is that the Board
back up their positive statements with their own money..... The Board all took a 100%
bonus in 2021, so they could have invested that in shares, but no kept the lot !!!
Post SPRINTER they told us to keep the faith in the data....They could have taken a pay cut..
Bought some shares?? No. Bother to keep us updated as promised at the AGM....NO!!!
Defending SNG currently is your choice, but back it up with facts, not the imaginary concept
that a deal is being done. IMHO!
Fruits
I see the more articulate version of you is posting on your account today...
You are obviously not doing a very good job, so they have to feed you
text! Saying that, it really is ridiculous to think we should use timelines
from 10 years ago to guide our current expectations.. Just an excuse for
a total lack of progress/updates. If we have not started a trial by the AGM
they will have to come up with something better than deals take a long time!
It seems RM & Co. never get a deal.... They over promise and under deliver.
RM said negtiations were ongoing after ACTIV2 to find a suitable trial..Nothing.
We were repeatedly told after SPRINTER deep dive there was a lot of interest
and they were throwing arrows/darts... Nothing! All we have is participation
in UNIVERSAL which is not even using our drug..... What a track record.. !! But
hey RM you awarded yourself a 100% bonus out of the placing funds, so if you do
come back looking for more funds, start by paying that back !!!
To be fair..
It is reasonable to wonder why SNG has not had a Partnership deal since 2014..
RM & Co sold us the story that SPRINTER results warranted further analysis..They touted our data around
every Conference in the sector but did not get any interest. After Activ2 was halted we were told
we were in discussions to look for an alternative trial..Nothing happened. I have a little experience
of following cancer drugs that show results but NICE turn down as not economically viable. My
concern here is that we seem very much adrift after 20 years listed and longer as a research outfit.
There is an unmet need for a broad spectrum anti viral, so you have to wonder why we are trying
to fund a trail and no BP has offered to Partner on a reasonable deal? Are we looking too niche
targeting the elderly who are seriously ill.... I think the answer is not far off... If we do not have
enough funds to complete our planned P2's then RM should be able to attract a JV/Partner
if the sector believes we have the potential to be commercial.. IF we do not have enough funds
and we have to get a financing deal/placing then I think the sector are not convinced....
Most here do not want to discuss this view, fair enough, just my thoughts as we wait for news!
Doc.Dan
We will only get a Partner if they get a large slice of the pie..
I guess TGF will have to be onboard whatever goes down...But
I know Tommy insists a Summer Trial is not an issue, but a Partner
may well want to wait for later in the year. I still think RM could
announce they want the UNIVERSAL results to define the design...!
There has never been an official announcement they are using the first 300
patients results, that was just another sweetner from RM at the AGM
to pacify disappointed shareholders IMHO!